Namal Nawana's most recent trade in Hologic, Inc. was a trade of 4,210 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hologic | Namal Nawana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 4,210 | 4,210 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Namal Nawana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,465 | 18,221 (0%) | 0% | - | Common Stock | |
| Hologic | Namal Nawana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,293 | 5,293 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Namal Nawana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,565 | 16,756 (0%) | 0% | - | Common Stock | |
| Hologic | Namal Nawana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 5,055 | 5,055 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Namal Nawana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 1,478 | 15,191 (0%) | 0% | - | Common Stock |